Photobiomodulation for temporomandibular disorders: A scoping review of laser-parameter reporting in controlled trials.

IF 5.4 4区医学 Q2 DENTISTRY, ORAL SURGERY & MEDICINE

Cranio-The Journal of Craniomandibular & Sleep Practice Pub Date : 2026-10-05 DOI:10.1080/08869634.2026.2736771

Kadambari Bharali, Kapil Hazarika, Nilutpal Deuri

{"title":"Photobiomodulation for temporomandibular disorders: A scoping review of laser-parameter reporting in controlled trials.","authors":"Kadambari Bharali, Kapil Hazarika, Nilutpal Deuri","doi":"10.1080/08869634.2026.2736771","DOIUrl":null,"url":null,"abstract":"Objective: To map the controlled-trial evidence on photobiomodulation (PBM) for temporomandibular disorders (TMDs), chart the laser dosimetric parameters, quantify reporting completeness, and identify standardization priorities.Methods: Scoping review per JBI methodology, reported per PRISMA-ScR, and registered on the Open Science Framework (project hdz53). PubMed/MEDLINE, the Cochrane Library (CENTRAL and CDSR), Lens.org, LILACS, and SciELO were searched from inception to July 21 2026. Eligible reports were randomized or non-randomized controlled trials in humans with TMD receiving PBM over the temporomandibular joint or masticatory muscles; reviews, uncontrolled designs, high-intensity or ablative laser, photodynamic therapy, and acupoint-only irradiation were excluded. Records were de-duplicated and screened independently by two reviewers in two stages, with third-reviewer arbitration. Ten dosimetric parameters were charted verbatim, omissions being the primary datum.Results: Of 1,733 records, 1,060 were screened after de-duplication and 462 reports were sought; 215 were not retrieved and 247 were assessed at full text. One hundred seventy‑five controlled trials (165 randomized) formed the evidence map, and 167 with an accessible full report were charted; all reporting-completeness proportions are of those 167. Wavelength and session number were reported in 159/167 trials (95%), power density in 20/167 (12%), and total delivered energy in 24/167 (14%). Only 31/167 (19%) reported every element of a minimum reproducibility set, 45/167 (27%) were non-reproducible, and protocols differed substantially within device families.Conclusion: Controlled trials of PBM for TMD describe the laser incompletely for the delivered dose to be reconstructed. A minimum reporting set, enforced at publication, is a critical step toward reproducible protocols.","PeriodicalId":56318,"journal":{"name":"Cranio-The Journal of Craniomandibular & Sleep Practice","volume":" ","pages":"1-14"},"PeriodicalIF":5.4000,"publicationDate":"2026-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cranio-The Journal of Craniomandibular & Sleep Practice","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/08869634.2026.2736771","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"DENTISTRY, ORAL SURGERY & MEDICINE","Score":null,"Total":0}

引用次数: 0

Abstract

Objective: To map the controlled-trial evidence on photobiomodulation (PBM) for temporomandibular disorders (TMDs), chart the laser dosimetric parameters, quantify reporting completeness, and identify standardization priorities.

Methods: Scoping review per JBI methodology, reported per PRISMA-ScR, and registered on the Open Science Framework (project hdz53). PubMed/MEDLINE, the Cochrane Library (CENTRAL and CDSR), Lens.org, LILACS, and SciELO were searched from inception to July 21 2026. Eligible reports were randomized or non-randomized controlled trials in humans with TMD receiving PBM over the temporomandibular joint or masticatory muscles; reviews, uncontrolled designs, high-intensity or ablative laser, photodynamic therapy, and acupoint-only irradiation were excluded. Records were de-duplicated and screened independently by two reviewers in two stages, with third-reviewer arbitration. Ten dosimetric parameters were charted verbatim, omissions being the primary datum.

Results: Of 1,733 records, 1,060 were screened after de-duplication and 462 reports were sought; 215 were not retrieved and 247 were assessed at full text. One hundred seventy‑five controlled trials (165 randomized) formed the evidence map, and 167 with an accessible full report were charted; all reporting-completeness proportions are of those 167. Wavelength and session number were reported in 159/167 trials (95%), power density in 20/167 (12%), and total delivered energy in 24/167 (14%). Only 31/167 (19%) reported every element of a minimum reproducibility set, 45/167 (27%) were non-reproducible, and protocols differed substantially within device families.

Conclusion: Controlled trials of PBM for TMD describe the laser incompletely for the delivered dose to be reconstructed. A minimum reporting set, enforced at publication, is a critical step toward reproducible protocols.

查看原文本刊更多论文

颞下颌疾病的光生物调节：对照试验中激光参数报告的范围综述。

目的：绘制光生物调节（PBM）治疗颞下颌疾病（TMDs）的对照试验证据，绘制激光剂量学参数图，量化报告的完整性，并确定标准化重点。方法：根据JBI方法进行范围审查，根据PRISMA-ScR报告，并在开放科学框架（项目hdz53）上注册。PubMed/MEDLINE、Cochrane图书馆（CENTRAL and CDSR）、Lens.org、LILACS和SciELO从成立到2026年7月21日进行了检索。符合条件的报告是在颞下颌关节或咀嚼肌上接受PBM治疗的TMD患者的随机或非随机对照试验；排除回顾、无控制设计、高强度或烧蚀激光、光动力治疗和仅穴位照射。记录由两名审稿人分两个阶段进行去重复和独立筛选，并由第三审稿人仲裁。10个剂量学参数被逐字绘制，遗漏为主要基准。结果：在1733份记录中，删除重复后筛选了1060份，寻求了462份报告；215篇未检索，247篇全文评估。175项对照试验（165项随机化）形成了证据图，167项具有可访问的完整报告被绘制成图表；所有报告完整性比例都是这167个比例。159/167次试验报告了波长和疗程数（95%），20/167次试验报告了功率密度（12%），24/167次试验报告了总传递能量（14%）。只有31/167（19%）报告了最小可重复性集的每个元素，45/167（27%）是不可重复性的，不同设备系列的方案存在很大差异。结论：PBM治疗TMD的对照试验对激光的描述不完全，无法重建给药剂量。在发布时强制执行的最小报告集是实现可复制协议的关键一步。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Cranio-The Journal of Craniomandibular & Sleep Practice DENTISTRY, ORAL SURGERY & MEDICINE-

CiteScore

4.50

自引率

12.50%

发文量

审稿时长

>12 weeks

期刊介绍： CRANIO: The Journal of Craniomandibular & Sleep Practice is the oldest and largest journal in the world devoted to temporomandibular disorders, and now also includes articles on all aspects of sleep medicine. The Journal is multidisciplinary in its scope, with editorial board members from all areas of medicine and dentistry, including general dentists, oral surgeons, orthopaedists, radiologists, chiropractors, professors and behavioural scientists, physical therapists, acupuncturists, osteopathic and ear, nose and throat physicians. CRANIO publishes commendable works from outstanding researchers and clinicians in their respective fields. The multidisciplinary format allows individuals practicing with a TMD emphasis to stay abreast of related disciplines, as each issue presents multiple topics from overlapping areas of interest. CRANIO''s current readership (thousands) is comprised primarily of dentists; however, many physicians, physical therapists, chiropractors, osteopathic physicians and other related specialists subscribe and contribute to the Journal.